midostaurin

Also Known As:

4'-N-benzoyl staurosporine; 4'-N-benzoylstaurosporine; CGP 41 251; CGP 41251; CGP-41251; N- ((9S,10R,11R,13R)- 10- methoxy- 9- methyl- 1- oxo- 2,3,10,11,12,13- hexahydro- 9,13- epoxy- 1H,9H- diindolo(1,2,3- GH:3',2',1'- lm)pyrrolo(3,4- j)(1,7)benzodiazonin- 11- yl)- n- methylbenzamide; PKC 412; PKC-412; PKC412; Rydapt; benzamide, N- (2,3,9,10,11,12- hexahydro- 9- methoxy- 8- methyl- 1- oxo- 8,12- epoxy- 1H,8H- 2,7b,12a- triazadibenzo(a,g)cyclonona(cde)trinden- 10- yl)- N- methyl- , (8alpha,9beta,10beta,12alpha)-; benzoylstaurosporine

Pharmalogical Action Categories:

D000970 - Antineoplastic Agents

Heterocyclic Compounds: 207
- Alkaloids: 5592
  - Indole Alkaloids: 206
    - Staurosporine: 967
      - midostaurin: 305
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 205
      - Indole Alkaloids: 206
        Staurosporine: 967
        midostaurin: 305
      - Carbazoles: 33
        Staurosporine: 967
        midostaurin: 305
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 206
        Staurosporine: 967
        midostaurin: 305
  - 3-Ring Heterocyclic Compounds
    - Carbazoles: 33
      - Staurosporine: 967
        midostaurin: 305

Anne-Sophie Otis Selected Research

Anne-Sophie Otis Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure